White label – Pompe disease - ClinicalTrials.eu

Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

Not recruiting

3 1 1 1
Investigated Diseases:
- Malignant melanoma stage III
- Malignant melanoma stage IV
Investigated Drugs:
- Nivolumab
- Relatlimab
+7
Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- B-cell lymphoma refractory
Investigated Drugs:
+3
Study of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
+6
Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
+7
Study on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Not recruiting

2 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- (2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
+1
Study on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

Not recruiting

3 1 1
Investigated Diseases:
- Relapsing-remitting multiple sclerosis
Investigated Drugs:
+11
Study Comparing Niraparib and Platinum-Taxane Drug Combination for Patients with Advanced Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Homologous recombination deficiency positive advanced ovarian cancer
- Ovarian cancer
Investigated Drugs:
Study on the Safety and Effectiveness of Cibotercept (KER-012) with Other Drugs for Adults with Pulmonary Arterial Hypertension

Not recruiting

2 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Cibotercept
Study on Switching to Emtricitabine, Tenofovir Alafenamide, and Bictegravir for HIV-1 Patients Unable or Unwilling to Continue Injectable Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study of Bosutinib for Children with Newly Diagnosed or Resistant Chronic Myeloid Leukemia

Not recruiting

1 1 1 1
Investigated Drugs:
- Bosutinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies